Patients' satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis

被引：0
|
作者：
Spessotto, Caroline [1 ]
Cavalli, Hanaie [2 ]
Eboni, Audred [3 ]
Machado, Rafael [4 ]
Mousquer, Analara [5 ]
Palazzo, Lara [4 ]
Finkelsztejn, Alessandro [4 ]
Goncalves, Marcos [3 ]
Sato, Henry [2 ]
Siquineli, Fabio [5 ]
Fragoso, Yara [2 ]
机构：
[1] Univ Metropolitana Santos, Sao Paulo, Brazil
[2] Inst Neurol Curitiba, Curitiba, Parana, Brazil
[3] Ctr Hosp Unimed Joinville, Joinville, Brazil
[4] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[5] Univ Reg Blumenau, Blumenau, Brazil
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
57
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [31] Disease-Modifying Drugs for Multiple Sclerosis in Pregnancy: A Systematic Review
    Lu, Ellen
    Wang, Bing Wei
    Guimond, Colleen
    Synnes, Anne
    Sadovnick, Dessa
    Tremlett, Helen
    NEUROLOGY, 2012, 78
  • [32] DISEASE-MODIFYING DRUGS FOR MULTIPLE SCLEROSIS IN PREGNANCY: A SYSTEMATIC REVIEW
    Charles, James A.
    NEUROLOGY, 2013, 80 (11) : 1068 - 1068
  • [33] Disease-modifying drugs for multiple sclerosis and JC virus expression
    Craig S. Miller
    Sidney A. Houff
    Jason Hopper
    Robert J. Danaher
    Julie A. Gurwell
    Yushun Lin
    Nubia Vega
    Joseph R. Berger
    Journal of NeuroVirology, 2012, 18 : 411 - 415
  • [34] Disease-modifying drugs for multiple sclerosis and JC virus expression
    Miller, Craig S.
    Houff, Sidney A.
    Hopper, Jason
    Danaher, Robert J.
    Gurwell, Julie A.
    Lin, Yushun
    Vega, Nubia
    Berger, Joseph R.
    JOURNAL OF NEUROVIROLOGY, 2012, 18 (05) : 411 - 415
  • [35] Disease-modifying drugs for multiple sclerosis in pregnancy A systematic review
    Lu, Ellen
    Wang, Bing Wei
    Guimond, Colleen
    Synnes, Anne
    Sadovnick, Dessa
    Tremlett, Helen
    NEUROLOGY, 2012, 79 (11) : 1130 - 1135
  • [36] Disease-modifying treatment of secondary progressive multiple sclerosis
    Hoffmann, Olaf
    Gold, Ralf
    NERVENARZT, 2021, 92 (10): : 1052 - 1060
  • [37] The impact of patient out-of-pocket costs and satisfaction with therapy on adherence to disease-modifying drugs in patients with multiple sclerosis
    Mayer, L.
    Smrtka, J.
    Gupta, S.
    Phillips, A. L.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 463 - 463
  • [38] Effects of the Treatment of Mothers with Multiple Sclerosis Using Disease-Modifying Drugs on Child Development
    Kasatkin D.S.
    Spirin N.N.
    Vinogradova T.V.
    Shitova A.S.
    Neuroscience and Behavioral Physiology, 2018, 48 (7) : 864 - 869
  • [39] ASSESSMENT OF PATIENT SATISFACTION WITH DISEASE MODIFYING DRUGS IN A COHORT OF MULTIPLE SCLEROSIS PATIENTS
    Ali, E.
    Counihan, T.
    Hennessy, J. M.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (01): : 124 - 124
  • [40] Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis
    Filippini, Graziella
    Del Giovane, Cinzia
    Clerico, Marinella
    Beiki, Omid
    Mattoscio, Miriam
    Piazza, Federico
    Fredrikson, Sten
    Tramacere, Irene
    Scalfari, Antonio
    Salanti, Georgia
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (04):
12345